St. Jude has been at the forefront of pediatric cancer research. Notably, it was the first institution to cure sickle cell disease with a bone marrow transplant. The hospital has also made significant advancements in the treatment of acute lymphoblastic leukemia (ALL), improving survival rates from 4% to 94%.
